[Treatment of congestive heart failure with beta-methyldigoxin (lanitop)].
Methylated Digoxin preparation--beta-Methyldigoxin (Lanitop) was used in 50 patients with congestive heart failure of different etiology (tablets of 0.3--0.6 mG per day). Its employment proved very effective in the treatment of congestive heart failure. It is not contraindicated to patients with chronic coronary insufficiency with underlying athrosclerotic cardiosclerosis with signs of congestive circulatory insufficiency. Side-effects of beta-Methyldigoxin are mild and noted rather seldom.
D000328:Adult; D000368:Aged; D004077:Digoxin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D004077:Digoxin
Lechenie bol'nykh s zastoĭnoĭ serdechnoĭ nedostatochnost'iu beta-metildigoksinom (lanitop).